| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Contents page 2
|
|
|
2011
|
16 |
11-12 |
p. iii-
1 p.
|
artikel
|
| 2 |
Contents page 1
|
|
|
2011
|
16 |
11-12 |
p. i-
1 p.
|
artikel
|
| 3 |
Deploying continuous improvement across the drug discovery value chain
|
Walker, Stephen M.
|
|
2011
|
16 |
11-12 |
p. 467-471
5 p.
|
artikel
|
| 4 |
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications
|
Pavan, Barbara
|
|
2011
|
16 |
11-12 |
p. 520-529
10 p.
|
artikel
|
| 5 |
Drug discovery management, small is still beautiful: Why a number of companies get it wrong
|
Knutsen, Lars J.S.
|
|
2011
|
16 |
11-12 |
p. 476-484
9 p.
|
artikel
|
| 6 |
Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation
|
Ghizzoni, Massimo
|
|
2011
|
16 |
11-12 |
p. 504-511
8 p.
|
artikel
|
| 7 |
Models for predicting blood–brain barrier permeation
|
Nielsen, Peter Aadal
|
|
2011
|
16 |
11-12 |
p. 472-475
4 p.
|
artikel
|
| 8 |
Targeting survivin in cancer: the cell-signalling perspective
|
Kanwar, Jagat R.
|
|
2011
|
16 |
11-12 |
p. 485-494
10 p.
|
artikel
|
| 9 |
The application of next-generation sequencing technologies to drug discovery and development
|
Woollard, Peter M.
|
|
2011
|
16 |
11-12 |
p. 512-519
8 p.
|
artikel
|
| 10 |
Therapeutic potential of anticancer immunotoxins
|
Choudhary, Swati
|
|
2011
|
16 |
11-12 |
p. 495-503
9 p.
|
artikel
|
| 11 |
The Ukrainian pharmaceutical market
|
Bondaryev, Timur B.
|
|
2011
|
16 |
11-12 |
p. 465-466
2 p.
|
artikel
|
| 12 |
Utility of protein structures in overcoming ADMET-related issues of drug-like compounds
|
Stoll, Friederike
|
|
2011
|
16 |
11-12 |
p. 530-538
9 p.
|
artikel
|
Tijdschrift beschrijving